European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance
All the chairs of Europe’s big pharma companies have written a public letter asserting that a shift in strategy is needed to close the gap to international rivals.
All the chairs of Europe’s big pharma companies have written a public letter asserting that a shift in strategy is needed to close the gap to international rivals.
Continuous manufacturing (CM) is increasingly being evaluated to integrate unit operations, enable closer process monitoring and reduce the intermediate handling and hold steps associated with conventional batch production. Realising those...
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Industry partnership will determine the success of the transition to low-GWP pMDIs
Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory
Turning AI skeptics into AI advocates through high-integrity data
Keeping pace with generative AI in pharmaceutical and healthcare organisations